Glomerular filtration rate and serum creatinine, Limitations to current definitions for AKI, Group member selection and meeting process, Evidence selection, appraisal, and presentation, Outcome selection judgments, values, and preferences, Grading the quality of evidence and the strength of recommendations, Staging AKI: Recommendations and Rationale, Examples of application of AKI definitions, Small kidneys as a marker of kidney damage, Vasopressors: Recommendations and Rationale, Protocolized Hemodynamic Management: Recommendations and Rationale, Protocolized hemodynamic management strategies in septic shock, Goal-directed therapy for hemodynamic support during the perioperative period in high-risk surgical patients, Glycemic control in critical illness: Recommendations and Rationale, Nutritional aspects in the prevention and treatment of critically ill patients with AKI, Total Energy Intake: Recommendations and Rationale, Protein Intake: Recommendations and Rationale, Nutrition route: Recommendations and Rationale, Dopamine for the prevention or treatment of AKI: Recommendations and Rationale, Fenoldopam for the prevention or treatment of AKI: Recommendations and Rationale, Natriuretic peptides for the prevention or treatment of AKI: Recommendations and Rationale, Recombinant Human (rh) IGF-1: Recommendations and Rationale, Treatment of Infections: Recommendations and Rationale, Patients with Normal Kidney Function in Steady State: Recommendations and Rationale, When Treatment with Multiple Daily Dosing is Used for More than 24 Hours: Recommendations and Rationale, When Treatment with Single-Daily Dosing is Used for More than 48 Hours: Recommendations and Rationale, Topical or Local Applications of Aminoglycosides: Recommendations and Rationale, Amphotericin B nephrotoxicity: Recommendations and Rationale, Treatment of Systemic Mycoses or Parasitic Infections: Recommendations and Rationale, On-pump vs. off-pump coronary artery bypass surgery: Recommendations and Rationale, N-ACETYLCYSTEINE (NAC): Recommendations and Rationale, NAC in critically ill patients: Recommendations and Rationale, Patients at Increased Risk for CI-AKI: Recommendations and Rationale, Dose/Volume of Contrast-Media Administration: Recommendations and Rationale, Route of administration of contrast media, Selection of a Contrast Agent: Recommendations and Rationale, High-osmolar vs. iso-osmolar or low-osmolar contrast media, Low-osmolar vs. iso-osmolar contrast media, Fluid Administration: Recommendations and Rationale, Use of oral fluids alone in patients at increased risk of CI-AKI: Recommendations and Rationale, Role of nac in the prevention of CI-AKI: Recommendations and Rationale, Theophylline: Recommendations and Rationale, Fenoldopam: Recommendations and Rationale, When to discontinue RRT: Recommendations and Rationale, Use of diuretics: Recommendations and Rationale, How to decide to use anticoagulation: Recommendations and Rationale, Patients without an increased bleeding risk or impaired coagulation and not already receiving effective systemic anticoagulation: Recommendations and Rationale, Patients with increased bleeding risk who are not receiving anticoagulation: Recommendations and Rationale, In patients with heparin-induced thrombocytopenia: Recommendations and Rationale, Uncuffed nontunneled dialysis catheter vs a tunneled catheter: Recommendations and Rationale, When choosing a vein for insertion of a dialysis catheter in patients with AKI: Recommendations and Rationale, Using ultrasound guidance for dialysis catheter insertion: Recommendations and Rationale, Obtaining a chest radiograph promptly after placement and before first use of an internal jugular or subclavian dialysis catheter: Recommendations and Rationale, Topical antibiotics: Recommendations and Rationale, Antibiotic locks: Recommendations and Rationale, Complementary therapies in AKI patients: Recommendations and Rationale, Hemodynamically unstable patients: Recommendations and Rationale, AKI patients with acute brain injury or other causes of increased intracranial pressure or generalized brain edema: Recommendations and Rationale, Protocols for decreasing hemodynamic instability with intermittent RRT, Buffer solution: Recommendations and Rationale, Dialysis fluids and replacement fluids in patients with AKI: Recommendations and Rationale, Kt/V and Effluent Volume Rates: Recommendations and Rationale, Getting Started: Patient Pathway to First Prescription, Overview of the Prescription Management Process, Suggested Timetable for Initial and Subsequent Clearance Measurements, Membrane Transport Characteristics and Preferred PD Modality, Automated Peritoneal Dialysis (APD) Regimens (Examples), Continuous Ambulatory Peritoneal Dialysis (CAPD) Regimen, International Clinical Practice Guideline Recommendations, EXTRANEAL (Icodextrin) PD Solution Important Risk Information, Gram-negative Bacilli Organism Peritonitis, Diagnosis and Management of Exit-site/Tunnel Infection, Oral Antibiotics Used in Exit-site and Tunnel Infections, Intraperitoneal Antibiotic Dosing Recommendations for CAPD Patients, Intermittent Dosing of Antibiotics in Automated Peritoneal Dialysis (APD), Preoperative and Postoperative PD Catheter Insertion Instructions for Patients, Principles of Accurate Peritoneal Dialysis Effluent Sampling and Culturing, Peritoneal Effluent Culture Laboratory Processing, Differential Diagnosis of Non-infectious Cloudy Effluent, Providing for a Safe Environment for Peritoneal Dialysis, Preoperative Mapping Using a Catheter Sample, Preoperative Mapping for Upper Abdominal and Presternal Catheters, Calculating Peritonitis Rates: An Example, Peritoneal Dialysis Prescription Management Quick Reference Guide, Predicting Progression with the PROPKD Score, Predicting Progression with Genetic Scoring, Predicting Progression with the Mayo Classification, Mayo ADPKD Prognostic Tool using Kidney Dimensions, Mayo ADPKD Prognostic Tool using Total Kidney Volume, Clinical Recommendation - Complete (CMAJ), CTFPHC Prostate-Specific Antigen Screening Video, Clinician Recommendations - Full (Annals of Internal Medicine), Clinician Recommendation - Complete (CMAJ), Summary of Recommendations for Clinicians and Policy-Makers.

By Justine Eacott Absolutely great app for tracking medications, best one I've used yet.

Predict the probability of respiratory insufficiency within the first week of admission, in individual patients with Guillain-Barré syndrome. Enter 0.25, 0.5, 1.5, 2.5 or multiple pills per 4, 8 or 12 hours, day or week. The peritoneal dialysis treatment prescription is the sole responsibility of the attending physician.

Report generated with Calculate by QxMD at https://www.qxmd.com/calculate, Over 400 decision support tools available • get the app for iOS or Android at qx.md/calculate. What is the incubation period for coronavirus disease 2019 (COVID-19)? What is the status of the antivirals lopinavir/ritonavir in the treatment of coronavirus disease 2019 (COVID-19)? Predict risk of intubation at 2, 6 and 12 hours in hypoxemic respiratory failure. Just put in the last fill date, day-supply prescribed and hit submit! Prescription Refill Calculator. Clinical Disease Activity Index for RA (CDAI). Calculate your refill due date in a second or two!

Those saying the 29 are not counting the fill date as day one.

This calculation assumes continuous ambulatory therapy (24 h) with exchange times of 4 hours and 1.0 L of UF daily.

Not yet validated in COVID-19.

Estimate risk of AKI after percutaneous coronary intervention, Identify a pre-renal state in patients using diuretics, Predict acute kidney injury in critically ill children. I'd love to see the author of this application expand upon the home page to show a little more information. What precautions should be taken by healthcare providers regarding coronavirus disease 2019 (COVID-19) patients? How many times you pause doing more important work to calculate if this patient can get this Rx filled or not? As used in the new MELD score, to correct Na in the setting of hyperglycemia, Amount of required sodium replenishment for the patient with hyponatremia, Estimate risk of progressive renal dysfunction in membranous nephropathy, International IgAN Prediction Tool - Adults, Determine prognosis in adults with IgA nephropathy, Estimate 6 month mortality on dialysis using the Cohen model, Dialysis Duration Needed for Methanol Ingestion, Estimate dialysis duration required for methanol poisoning, Dialysis Duration Needed for Ethylene Glycol Ingestion, Estimate dialysis duration required for ethylene glycol poisoning, Guide Transplant Referral for Incident Dialysis Patients Over 70, Guide renal transplant referral with this mortality estimate for dialysis patients 70 years or older at dialysis start. © 2020 Quick Base. What are common laboratory findings in patients with coronavirus disease 2019 (COVID-19)?

Assess disease activity in rheumatoid arthritis. Assess likelihood of fibrosis or cirrhosis non-invasively using AST and platelet count. In no event will the creators of this application nor any related third parties be liable for any loss or damage whatsoever arising from or in connection with the use of this application. The estimated maximum fill volume may not be applicable to extremely large or very small patients. What are risk factors for severe illness in patients with coronavirus disease 2019 (COVID-19)?

… You accepted the above disclaimer and policies on, If you would like to revoke your acceptance of the disclaimer and policies, please click the button below. … Determine prognosis in diffuse large B-cell lymphoma.

This app does it for you!- In less than 3 seconds!

Track extra Pills/Doses 15. ASDAS-ESR (Ankylosing Spondylitis Disease Activity Score), Assess disease activity in Ankylosing Spondylitis, Adult Onset Still's Disease, Diagnostic Criteria, Scleroderma/Systemic Sclerosis (2013 EULAR/ACR Criteria), Review EULAR/ACR criteria for scleroderma, Behcet’s Syndrome International Study Group Criteria. What are the signs and symptoms of coronavirus disease 2019 (COVID-19)? A time-saver! If you do not consent to our use of cookies, please close this application now. Assess disease activity in relapsing polychondritis.

By Yvonne Fox A really good app for helping me remember when to take medication. A patient's residual renal function (RRF) can be considered when modeling a PD prescription.

Try This App This application is designed to help track prescriptions and the doctor that prescribed them. Dialysis Risk After Cardiac Surgery (Cleveland Clinic Score by Thakar). The PD Calculator is not intended to be used for pediatric patients or amputees. All Rights reserved. You can order up to 6 different prescription items at a time - use the form repeatedly if you need to order more than 6 items. We welcome your feedback.

Bleeding Risk in Atrial Fibrillation: OBRI. This application and our third party analytics and advertising partners may collect non-personally identifiable information about you and your device in order to improve this application and optimize displayed advertisements. The SLICC criteria are validated criteria for making the diagnosis of lupus. Predict the probability of being unable to walk independently during follow up in patients with Guillain-Barré syndrome.

Be fitter. Any reliance you place on such information is strictly at your own risk. $4.87/month for a 1-year plan, Number of IP addresses: 50,000 The results will be computed once all questions are answered. The prescription calculator for pharmacists and pharmacy technicians. … It is essential that the physician adjusts the prescription according to the individual patient's clinical parameters to ensure the adequacy of the PD prescription. What is the status of azithromycin in the treatment of coronavirus disease 2019 (COVID-19)? Terms and conditions, features, support, pricing, and service options subject to change without notice. Number of servers: 2,500 This app is must-have for health providers like: Physicians, Physician Assistants, Nurse Practitioners, Pharmacists and other health professionals associated with prescribing and dispensing medications.